{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-027053","form_type":"8-K","ticker":"MIRA","cik":"0001904286","company_name":"MIRA PHARMACEUTICALS, INC.","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.045979+00:00","generated_at":"2026-06-12T05:00:26.177301+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"MIRA Pharmaceuticals closes $8.9M IPO; shares begin trading on Nasdaq","bullets":["Priced 1,275,000 shares at $7.00; gross proceeds of $8.9M.","Nasdaq Capital Market listing under 'MIRA'; trading began Aug 3, 2023.","Underwriters granted 45-day over-allotment option for 191,250 shares.","Issued representative's warrants for 63,750 shares at $7.00, exercisable for 5 years.","Shares issued to MZ as compensation for IPO-related services remain unregistered."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-027053","json":"https://secwatch.observer/filing/0001493152-23-027053.json","markdown":"https://secwatch.observer/filing/0001493152-23-027053.md","text":"https://secwatch.observer/filing/0001493152-23-027053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223027053/0001493152-23-027053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223027053/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T05:00:26.177301+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e8b72e219ef595ed40f011496b2721b4317ec1a4","claim":"MIRA PHARMACEUTICALS, INC. entered into Underwriting Agreement with Kingswood Investments, division of Kingswood Capital Partners, LLC (effective 2023-08-02).","evidence_excerpt":"On August 2, 2023, MIRA Pharmaceuticals, Inc. (the “Company”) entered into an Underwriting Agreement with Kingswood Investments, division of Kingswood Capital Partners, LLC (“Kingswood”) on behalf of itself and as representative of the underwriters named therein (the “Underwriting Agreement”), pursuant to which the Company issued and sold, in an underwritten public offering (the “Public Offering”), 1,275,000 shares of common stock, $0.0001 par value per share (“Common Stock”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223027053/0001493152-23-027053-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Kingswood Investments, division of Kingswood Capital Partners, LLC"},{"label":"Effective","value":"2023-08-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}